{"data":{"ticker":"ABBV","name":"AbbVie Inc.","cik":"0001551152","quarterly":[{"frame":"CY2023Q3","end":"2023-09-30","revenue":13927000000,"netIncome":1778000000,"epsDiluted":1},{"frame":"CY2023Q4","end":"2023-12-31","revenue":14301000000,"netIncome":822000000,"epsDiluted":0.46},{"frame":"CY2024Q1","end":"2024-03-31","revenue":12310000000,"netIncome":1369000000,"epsDiluted":0.77},{"frame":"CY2024Q2","end":"2024-06-30","revenue":14462000000,"netIncome":1370000000,"epsDiluted":0.77},{"frame":"CY2024Q3","end":"2024-09-30","revenue":14460000000,"netIncome":1561000000,"epsDiluted":0.88},{"frame":"CY2024Q4","end":"2024-12-31","revenue":15102000000,"netIncome":-22000000,"epsDiluted":-0.02},{"frame":"CY2025Q1","end":"2025-03-31","revenue":13343000000,"netIncome":1286000000,"epsDiluted":0.72},{"frame":"CY2025Q2","end":"2025-06-30","revenue":15423000000,"netIncome":938000000,"epsDiluted":0.52},{"frame":"CY2025Q3","end":"2025-09-30","revenue":15776000000,"netIncome":186000000,"epsDiluted":0.1},{"frame":"CY2025Q4","end":"2025-12-31","revenue":16618000000,"netIncome":1816000000,"epsDiluted":1.02},{"frame":"CY2026Q1","end":"2026-03-31","revenue":15002000000,"netIncome":695000000,"epsDiluted":0.39},{"frame":"CY2026Q2","end":"2026-06-30","revenue":16990000000,"netIncome":3613000000,"epsDiluted":2.03}],"annual":[{"frame":"CY2020","end":"2020-12-31","revenue":45804000000,"netIncome":4616000000,"operatingCashFlow":17588000000,"capex":798000000,"buybacks":978000000,"dividends":7716000000},{"frame":"CY2021","end":"2021-12-31","revenue":56197000000,"netIncome":11542000000,"operatingCashFlow":22777000000,"capex":787000000,"buybacks":934000000,"dividends":9261000000},{"frame":"CY2022","end":"2022-12-31","revenue":58054000000,"netIncome":11836000000,"operatingCashFlow":24943000000,"capex":695000000,"buybacks":1487000000,"dividends":10043000000},{"frame":"CY2023","end":"2023-12-31","revenue":54318000000,"netIncome":4863000000,"operatingCashFlow":22839000000,"capex":777000000,"buybacks":1972000000,"dividends":10539000000},{"frame":"CY2024","end":"2024-12-31","revenue":56334000000,"netIncome":4278000000,"operatingCashFlow":18806000000,"capex":974000000,"buybacks":1708000000,"dividends":11025000000},{"frame":"CY2025","end":"2025-12-31","revenue":61160000000,"netIncome":4226000000,"operatingCashFlow":19030000000,"capex":1214000000,"buybacks":980000000,"dividends":11657000000}],"latest":{"end":"2026-06-30","cash":6569000000,"debt":null,"equity":-5935000000,"assets":135115000000,"sharesOutstanding":1767117285,"sharesDate":"2026-07-27","form":"10-Q"},"source":"SEC XBRL companyfacts, values as filed in USD"},"updatedAt":"2026-09-14T14:52:26.147Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}